AJ Vaccines is a Danish-based pharmaceutical company with a global presence, dedicated to the development, manufacturing, and distribution of high-quality vaccines for serious infectious diseases. Building on over a century of vaccine production heritage from the Statens Serum Institut (SSI), AJ Vaccines plays a crucial role in global health by supplying vaccines to organizations like UNICEF and WHO, as well as to national governments. The company focuses on ensuring the availability of essential vaccines and investing in research and development for future vaccine needs.
The headquarters serves as the central hub for AJ Vaccines' global operations, encompassing research and development, advanced vaccine manufacturing, quality assurance, commercial activities, and corporate administration.
Located on a campus renowned for its long history in public health and vaccine research, the facilities include state-of-the-art vaccine production units, modern laboratories, and preserved historic buildings.
AJ Vaccines fosters a science-driven, quality-focused, and collaborative work environment. Employees are dedicated to innovation and making a tangible impact on global health, leveraging Denmark's strong legacy in vaccine production.
The headquarters is of paramount significance as it houses the company's core manufacturing and R&D capabilities, continuing Denmark's century-long tradition of producing critical vaccines for both national and international markets.
AJ Vaccines maintains a significant global presence by developing, manufacturing, and distributing essential vaccines to countries worldwide. Key functions supported globally include: vaccine supply to major international procurers like UNICEF and WHO for global immunization programs; managing regulatory approvals and market access in numerous countries across different continents; and engaging in international collaborations for clinical development and public health initiatives. Their products reach over 50 countries, contributing to disease prevention on a global scale.
Artillerivej 5
Copenhagen S
Capital Region of Denmark
Denmark
Address: N/A - Operations managed via Copenhagen HQ and global partnerships
To ensure widespread global access to its life-saving vaccines through strategic partnerships, direct engagement with international health organizations like WHO and UNICEF, and efficient supply chain management.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AJ Vaccines' leadership includes:
AJ Vaccines has been backed by several prominent investors over the years, including:
In the past year, AJ Vaccines has strengthened its executive team, notably with the appointment of a new Chief Operating Officer. This reflects the company's ongoing focus on enhancing operational excellence and supporting its growth trajectory. No major executive exits have been publicly announced.
Discover the tools AJ Vaccines uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AJ Vaccines typically uses an email format based on employee initials followed by the company domain '@ajvaccines.com'. For example, an employee named Jesper Helmuth Larsen would likely have an email address using his initials.
[initials]@ajvaccines.com
Format
jhl@ajvaccines.com
Example
75%
Success rate
ajvaccines.com • February 12, 2024
AJ Vaccines announced strong financial results for 2023, showcasing significant revenue growth and an enhanced market position. The company reiterated its commitment to global vaccine supply and continued investments in R&D and production capabilities....more
AJ Vaccines LinkedIn • February 2, 2024
AJ Vaccines announced the appointment of Jerome Cabannes as its new Chief Operating Officer (COO), effective January 2024. Mr. Cabannes will leverage his extensive experience in pharmaceutical operations to lead the company's manufacturing and supply chain functions....more
ajvaccines.com • December 19, 2023
AJ Vaccines secured a significant tender from UNICEF for the continued supply of its Tetanus Toxoid (TT) vaccine for the period 2024-2026. This win underscores AJ Vaccines' role as a key global supplier for essential immunization programs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AJ Vaccines, are just a search away.